Green Cross Plans to Launch Mass Production of Human Placenta Injectable Preparations

Green Cross Holdings and Japan Bioproducts Industry Co. Ltd (Tokyo, Japan) recently agreed to form a joint venture to launch a domestic mass production of human placenta injectable preparations, with an expected start date of May.

The formation of the joint venture, known as GC Japan Bio Corp., is based on the existing relationship between the two companies, where Green Cross has been import...